Fellowship · Evanston, IL
Sponsored by University of Chicago Medical Center
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet (London, England) · 2021 · 160 citations · Omer Kucuk
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 182 citations · Bruce Brockstein
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
Nature communications · 2021 · 121 citations · Omer Kucuk
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
Nature communications · 2022 · 66 citations · Omer Kucuk
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Nature cancer · 2025 · 16 citations · Omer Kucuk
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Cancer · 2023 · 43 citations · Omer Kucuk
Couple-based communication intervention for head and neck cancer: a randomized pilot trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021 · 34 citations · Bruce Brockstein
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
Journal for immunotherapy of cancer · 2021 · 63 citations · Omer Kucuk